ENTITY
Hygeia Healthcare

Hygeia Healthcare (6078 HK)

103
Analysis
Health Care • China
Hygeia Healthcare is a prominent oncology healthcare group in China, dedicated to enhancing the accessibility and affordability of cancer treatment services. The company operates a network of oncology hospitals, providing comprehensive services from screening and diagnosis to various treatment modalities like chemotherapy, immunotherapy, and radiotherapy. It also offers radiotherapy consulting and equipment licensing. Hygeia Healthcare was founded in 2009 and is headquartered in Shanghai, China.
more
bullish•Hygeia Healthcare
•05 May 2026 23:46•Primer

Primer: Hygeia Healthcare Group (6078 HK) - May 2026

Hygeia is the largest private oncology healthcare group in China, strategically expanding its hospital network through both greenfield projects...

Logo
αSK
100 Views
Share
bullish•Cross Asset Strategy
•29 Jan 2024 08:33

China Macro: Sector Positioning Update

Sector positioning among active China Funds.  Industrials and Consumer Staples Remain Top Overweights, Energy shows signs of a turnaround, whilst...

Logo
592 Views
Share
bearish•Hygeia Healthcare
•02 Sep 2025 08:30

Hygeia Healthcare (6078 HK): Prolonged Winter? Or Is There Light Visible At the End of the Tunnel?

​Hygeia Healthcare reports 16% revenue decline in 1H25, dragged by decrease in inpatient revenues. Growth advantage from inorganic expansion wanes....

Logo
258 Views
Share
•29 Mar 2026 08:30

APAC Healthcare Weekly (March 29) – Hansoh, CSPC, Chugai, Takeda, Otsuka, Celltrion, Alteogen

Hansoh got trial approval, while CSPC obtained new drug approval. Chugai’s partner is discontinuing development of emugrobart. Otsuka is acquiring...

Logo
296 Views
Share
•24 Aug 2025 08:30

APAC Healthcare Weekly (Aug 24) – Wuxi Bio, Ab&B Bio, Ascletis Pharma, Remegen, Daiichi Sankyo, CSL

Wuxi Bio got EMA nod for Ireland manufacturing facility. Daiichi Sankyo got breakthrough therapy designation for its drug candidate in US. CSL...

Logo
666 Views
Share
x